Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.54 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.54 |
| ▸ | CLK1 | P49759 | 11/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.53 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CLK2 | P49760 | 2/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL762071 | 0.85 | BACE1 (0.59) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL29239834 | 0.83 | CA2 (0.57) | BACE1CA2PDE3BPDE3ACYP1A2 | |
| SCHEMBL144533 | 0.82 | BACE1 (0.65) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL5546367 | 0.80 | BACE1 (0.62) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL16023592 | 0.80 | BACE1 (0.62) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL2175746 | 0.80 | BACE1 (1.00) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL826722 | 0.79 | CYP2A6 (0.52) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL3478352 | 0.78 | HSP90AA1 (0.49) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL12778904 | 0.76 | BACE1 (0.57) | BACE1CA2PDE3BPDE3ACLK1 | |
| SCHEMBL6839989 | 0.76 | BACE1 (0.62) | BACE1CA2PDE3BPDE3ACLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080076800-A1 | Benzene, Pyridine, and Pyridazine Derivatives | SERENEX, INC. | 2008-03-27 | — | — | US | disclosed |
| WO-2008024963-A1 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES | SERENEX, INC. (US) | 2008-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076800-A1 | Benzene, Pyridine, and Pyridazine Derivatives | RB1, MKI67, CCNB1 | BACE1 3691/4885CA2 3154/4885PDE3B 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.